An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis.
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Gabapentin (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Pfizer
- 28 Oct 2008 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 28 Oct 2008 Planned end date changed from 1 Dec 2008 to 1 Dec 2007 as reported by ClinicalTrials.gov.
- 28 Oct 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.